Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SKYA SkyAI, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.95 +6.6% | $16.31 +6.3% |
| StockIQ Score | 57C Moderate Risk: Medium | 42D Weak Risk: Medium |
| Technical | 80A- | 36F |
| Fundamental | 39F | 35F |
| Growth | 52C- | 50C- |
| Fair Value | 55C | 38F |
| News | 50C- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
SkyAI (SKYA) outperforms Ascentage Pharma (AAPG) in technicals and fundamentals, with scores of 80 versus 36 and 39 versus 35, respectively. Its investor score (57) is also higher than AAPG’s (42), and it carries a stronger "MODERATE" rating compared to AAPG’s "WEAK." However, AAPG’s growth score (50) slightly edges out SKYA’s (52) by 2 points. Valuation scores are closer, with SKYA at 55 and AAPG at 38.
